Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03703050
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2018-10-09
Brief Title:
Nivolumab for Pediatric and Adult RelapsingRefractory ALK for Evaluation of Response in Patients With Progressive Disease Cohort 1 or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse Cohort 2
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-09
First Submit QC Date:
October 10 2018
Study First Post Date:
2018-10-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-10
Last Update Post Date:
2024-06-11
Last Update Post Date Type:
ACTUAL